Dare Bioscience announces DARE-FRT1 data published.
Dare Bioscience announced the article entitled "Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep" was published online in the journal Drug Delivery and Translational Research. The goal of the research was to characterize the in vitro release, pharmacokinetics and local tolerability of DARE-FRT1, a novel ethylene-vinyl acetate intravaginal ring, or IVR, drug delivery technology delivering progesterone, in drug-naive ovariectomized female Dorset crossbred sheep. DARE-FRT1 is being developed as an optimized IVR technology capable of delivering bio-identical progesterone hormone for the prevention of preterm birth and for pregnancy maintenance and support as part of an assistive reproductive technology procedure. DARE-FRT1 is designed to allow for convenient non-invasive, non-oral administration of bio-identical progesterone over a 14-day period.
|Printer friendly Cite/link Email Feedback|
|Date:||May 8, 2019|
|Previous Article:||LiveXLive Media signs distribution agremeent with China's Tencent Video.|
|Next Article:||Walmart on track to reduce 1B metric tons of emission from supply chain by 2020.|